Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Change in Accured Expenses (2018 - 2019)

Historic Change in Accured Expenses for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to $227000.0.

  • DiaMedica Therapeutics' Change in Accured Expenses rose 17668.92% to $227000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $226000.0, marking a year-over-year decrease of 4378.11%. This contributed to the annual value of $2.5 million for FY2024, which is 61522.99% up from last year.
  • Latest data reveals that DiaMedica Therapeutics reported Change in Accured Expenses of $227000.0 as of Q4 2019, which was up 17668.92% from $195000.0 recorded in Q3 2019.
  • Over the past 5 years, DiaMedica Therapeutics' Change in Accured Expenses peaked at $409000.0 during Q3 2018, and registered a low of -$296000.0 during Q4 2018.